Literature DB >> 9337148

Inducible nitric oxide synthase-deficient mice have enhanced leukocyte-endothelium interactions in endotoxemia.

M J Hickey1, K A Sharkey, E G Sihota, P H Reinhardt, J D Macmicking, C Nathan, P Kubes.   

Abstract

Nitric oxide (NO) from constitutive NO synthase (NOS) has been postulated to be a homeostatic regulator of leukocyte-endothelial cell interactions. By contrast, the inducible NO synthase (iNOS) isoform has been invoked as a potential pathogenic enzyme in numerous inflammatory diseases. The objective of this study was to determine whether the iNOS isoform is also capable of functioning as a regulator of leukocyte recruitment. Mice received endotoxin (LPS, 30 microg/kg, i.v.); 2-4 h later, intravital microscopy was used to examine leukocyte rolling and adhesion in postcapillary venules of the cremaster muscle and the sinusoids and postsinusoidal venules of the hepatic microcirculation. Leukocyte recruitment into the lung was also examined. RT-PCR confirmed that this treatment induced iNOS mRNA expression in wild-type mice as early as 2 h after LPS treatment. Between 2 and 4 h after LPS administration, the number of rolling and adherent leukocytes in cremasteric postcapillary venules and of adherent cells in liver postsinusoidal venules of iNOS-deficient mice were significantly higher than in wild-type mice. Leukocyte accumulation in the lung (measured by myeloperoxidase assay) was also significantly elevated in iNOS-deficient animals. These effects could not be attributed to differences in systemic blood pressure, shear rates, circulating leukocyte numbers, or baseline levels of rolling and adhesion because these parameters were not different between the two groups. To establish whether the differences in leukocyte recruitment were related to the leukocytes per se, perfusion of iNOS+/+ or iNOS-/- septic blood over purified E-selectin (using parallel plate flow chambers) revealed much larger recruitment of iNOS-/- leukocytes. These results suggest that iNOS induced in response to LPS releases NO that is capable of reducing leukocyte accumulation by affecting leukocytes directly and raises the possibility that induction of iNOS is a homeostatic regulator for leukocyte recruitment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337148     DOI: 10.1096/fasebj.11.12.9337148

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  66 in total

1.  Endothelium-derived Toll-like receptor-4 is the key molecule in LPS-induced neutrophil sequestration into lungs.

Authors:  Graciela Andonegui; Claudine S Bonder; Francis Green; Sarah C Mullaly; Lori Zbytnuik; Eko Raharjo; Paul Kubes
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

2.  21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties.

Authors:  M Paul-Clark; P Del Soldato; S Fiorucci; R J Flower; M Perretti
Journal:  Br J Pharmacol       Date:  2000-12       Impact factor: 8.739

3.  P-selectin-mediated monocyte-cerebral endothelium adhesive interactions link peripheral organ inflammation to sickness behaviors.

Authors:  Charlotte D'Mello; Kiarash Riazi; Tai Le; Katarzyna M Stevens; Arthur Wang; Derek M McKay; Quentin J Pittman; Mark G Swain
Journal:  J Neurosci       Date:  2013-09-11       Impact factor: 6.167

4.  MCP-1/CCR2 signalling pathway regulates hyperoxia-induced acute lung injury via nitric oxide production.

Authors:  Toshiyuki Okuma; Yasuhiro Terasaki; Naomi Sakashita; Koichi Kaikita; Hironori Kobayashi; Takanori Hayasaki; William A Kuziel; Hideo Baba; Motohiro Takeya
Journal:  Int J Exp Pathol       Date:  2006-12       Impact factor: 1.925

5.  Role of inducible nitric oxide synthase in the regulation of neutrophil migration in zymosan-induced inflammation.

Authors:  M N Ajuebor; L Virág; R J Flower; M Perretti; C Szabó
Journal:  Immunology       Date:  1998-12       Impact factor: 7.397

6.  Inducible nitric oxide synthase (iNOS) activity promotes ischaemic skin flap survival.

Authors:  A J Kane; J E Barker; G M Mitchell; D R Theile; R Romero; A Messina; M Wagh; F O Fraulin; W A Morrison; A G Stewart
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

7.  Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid.

Authors:  Riku Korhonen; Riitta Korpela; Eeva Moilanen
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092

8.  Resolution of experimental lung injury by monocyte-derived inducible nitric oxide synthase.

Authors:  Franco R D'Alessio; Kenji Tsushima; Neil R Aggarwal; Jason R Mock; Yoshiki Eto; Brian T Garibaldi; Daniel C Files; Claudia R Avalos; Jackie V Rodriguez; Adam T Waickman; Sekhar P Reddy; David B Pearse; Venkataramana K Sidhaye; Paul M Hassoun; Michael T Crow; Landon S King
Journal:  J Immunol       Date:  2012-07-27       Impact factor: 5.422

9.  Niacin inhibits carrageenan-induced neutrophil migration in mice.

Authors:  Raphael Gomes Ferreira; Tamires Cardoso Matsui; Lindisley Ferreira Gomides; Adriana Martins Godin; Gustavo Batista Menezes; Márcio de Matos Coelho; André Klein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-03-26       Impact factor: 3.000

10.  Nitric oxide synthase isoforms play distinct roles during acute peritonitis.

Authors:  Jie Ni; Rachel M McLoughlin; Alexandre Brodovitch; Pierre Moulin; Peter Brouckaert; Barbara Casadei; Olivier Feron; Nicholas Topley; Jean-Luc Balligand; Olivier Devuyst
Journal:  Nephrol Dial Transplant       Date:  2009-08-25       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.